Delivery Order SPE2DB22D2006-SPE2DB24FW3KY

Award Date 9/10/24
Potential Completion Date 9/11/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order is for the drug Kerendia 10 mg Tablet 30s, with a ceiling value of $3,377.11 and a completion date of October 23, 2024. The contract is a firm fixed-price delivery order with no set-aside requirements, indicating open competition. As a large IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of 90 tablets of the drug Kerendia 10 mg, with a total ceiling value of $8,025.30. The contract is a firm fixed-price delivery order with an ultimate completion date of August 7, 2024. This order is not associated with any set-aside program. Amerisourcebergen has been awarded numerous federal contracts and indefinite delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,293.50 firm fixed-price delivery order is for the supply of the drug KERENDIA 10 MG TABLET 30S. The contract has an ultimate completion date of February 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,311.96 firm fixed-price contract is for the supply of the prescription medication KERENDIA 10 MG TABLET 30S. The award has an ultimate completion date of September 19, 2024. Amerisourcebergen holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4563927541 KERENDIA 10 MG TABLET 90S, a medical product, with a ceiling value of $6,727.66 and a period of performance ending on March 12, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $7,001.19, is for the supply of the pharmaceutical product KERENDIA 10 MG TABLET 90S. The contract is a firm fixed-price type with a completion date of July 19, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,536.04 firm fixed-price delivery order is for the supply of KERENDIA 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,669.83, is for the delivery of Kerendia 10 mg tablet medical products. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,380.41, is for the delivery of the medication KERENDIA 10 MG TABLET 30S. The contract is a Firm Fixed Price type and has a period of performance through March 29, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,463.06 Firm Fixed Price delivery order covers the supply of 4567199394 KERENDIA 10 MG TABLET 30S, a pharmaceutical product, with a period of performance through February 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW3KY
    Delivery Order

This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply the drug Kerendia 10 mg tablets. The $4,433.76 contract has a completion date of September 11, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, for providing a wide range of pharmaceutical and medical supplies to support federal healthcare programs and facilities nationwide. This delivery order is not designated as a set-aside.

Generated 12/10/24, 2:13 PM